Search results for: 'Cancer Diagnostics Market, liquid biopsy'

27 Aug 2020  |  Global  |  Market Research

Smart Labs as Key Drivers for the Digital Transformation of Diagnostic Laboratories, 2020

Robotic Automation, Internet of Things (IoT), and Artificial Intelligence (AI) Offering Growth Opportunities for Academic and Commercial Diagnostics Labs

Infographics

×

Key Issues Addressed

Diagnostic academic and commercial research labs suffer from cost pressures, given the ongoing Protecting Access to Medicare Act (PAMA) regulations and reproducibility issues, and are under productivity strain. The recent COVID-19 pandemic leading to increasing test volumes and renewed focus on research and development (R&D) to drive innovation wil...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) highlights recent advances in biological therapies such as RNA therapies, biosimilars, gene therapies and cell therapies for the management of diseases such as cancer, neurodegenerative disorders and rare diseases. The research also provides technological insigh...

The aim of this research service is to analyse the diabetes diagnostics market in Europe and provide strategic recommendations and conclusions for the success of its participants. The main objective of this research service is to establish an understanding of the key diabetes diagnostics market segments (laboratory-based HbA1C diagnostics, SMBG and...

This research service explores the market for therapeutics used for the treatment of breast cancer in the Unites States of America. It analyzes the various challenges faced by pharmaceutical companies, and the competitive advantages and disadvantages of their products in the market.

The diabetes diagnostics market in China is classified into two market segments as laboratory diabetes diagnostics segment and POCT diabetes diagnostics segment. The analysis time frame for this study was from 2005 to 2012{CAGR period}, with 2005 being the base year of the study. The forecast period is 2006 to 2012 and historic period is 2002 to 20...

The Global Cancer Therapeutics Market is a fast growing market that is relying heavily on new drugs. The total therapeutic market is expected to grow from $23.1 billion in 2004 to $60.6 billion in 2011. The targeted therapy segment is providing the growth of the entire market with an expected compound annual growth rate of 24.1 percent for 2004-2...

The U.S. Osteoporosis Diagnostics Market report focuses on the varying dynamics of the bone densitometry market. This report covers Osteoporosis Diagnostics equipment for axial and peripheral measurement sites, over a ten-year period. Osteoporosis technologies relating to this report include DXA, QCT, Quantitative Ultrasound and Radiographic Abso...

This research service provides market intelligence, analysis, and forecasts for the U.S. immunoassay diagnostics market. A detailed analysis is provided with regard to these immunoassay diagnostic tests, immunoassay analyzers, companies that manufacture and distribute them, and end-users that purchase them. The forecast period is 2007 through 2013 ...

This research service provides market intelligence, analysis, and forecasts for the U.S. molecular diagnostics markets. The products discussed in this research service are in vitro diagnostic kits, consumables, and instruments. A detailed analysis is provided with regard to these products and the companies that manufacture and distribute them. The...